JMM vs JPM

JMM presents a classic deep-value profile, with a Piotroski F-Score of 6/9 indicating stable financial health and a current price ($5.78) trading at a significant discount to both its Graham Number ($8.63) and Intrinsic Value ($14.07). While valuation metrics are highly attractive—specifically a P/E of 11.56 against a sector average of 35.49—the asset is hampered by a completely bearish technical trend (0/100) and weak insider sentiment (40/100). The fund shows decent earnings growth (14.1%), but the extreme disconnect between intrinsic value and market price suggests a value trap or a lack of market catalyst. Overall, it is a strong candidate for income-focused value investors, but a risky bet for growth or momentum traders.

JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.